Stanley Perlman
University of Iowa
H-index: 108
North America-United States
Top articles of Stanley Perlman
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models | Advanced science | Yanjun Zhang Jing Sun Jian Zheng Suxiang Li Haiyue Rao | 2024/3 |
Monovalent SARS-CoV-2 mRNA vaccine does not boost Omicron-specific immune response in diabetic and control pediatric patients | The Journal of infectious diseases | Alan Sariol Molly A Vickers Shannon M Christensen Daniela Weiskopf Alessandro Sette | 2023/8/25 |
Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment | Mbio | Pengfei Li Yunjeong Kim Chamandi S Dampalla Harry Nhat Nguyen David K Meyerholz | 2024/2/14 |
Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike | Timothy JC Tan Abby Odle Ruipeng Lei Kenneth A Matreyek Stanley Perlman | 2023 | |
Suggested searches | Perspective | Sunkyung Kim Jing Chen Feiya Ou Tian-Tian Liu Suin Jo | 2024/3/4 |
Anticipating a MERS-like coronavirus as a potential pandemic threat | The Lancet | Alimuddin Zumla Malik Peiris Ziad A Memish Stanley Perlman | 2024/4/8 |
Adaptation of SARS-CoV-2 to ACE2H353K mice reveals new spike residues that drive mouse infection | Journal of virology | Kun Li Abhishek Verma Pengfei Li Miguel E Ortiz Grant M Hawkins | 2024/1/23 |
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination | Nature Immunology | Valeria Fumagalli Micol Ravà Davide Marotta Pietro Di Lucia Elisa B Bono | 2024/3/14 |
AT cell–based SARS-CoV-2 spike protein vaccine provides protection without antibodies | JCI insight | Juan Shi Jian Zheng Xiujuan Zhang Wanbo Tai Ryan Compas | 2024/3/3 |
Proviral role of caspase-6 in coronavirus infections | Cell research | Lok-Yin Roy Wong Stanley Perlman | 2023/1 |
Coronavirus research: knowledge gaps and research priorities | Stanley Perlman Malik Peiris | 2023/3 | |
What’s what in a pandemic? Virus, disease, and societal disaster must be differentiated | PLoS biology | Alexander E Gorbalenya Stanley Perlman | 2023/5/25 |
Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge | Iscience | Xiaoqing Guan Abhishek K Verma Gang Wang Juan Shi Stanley Perlman | 2023/10/20 |
Correction for Castaño-Rodriguez et al.,“Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis” | mBio | Carlos Castaño-Rodríguez Jose M Honrubia Javier Gutierrez-Álvarez Marta L DeDiego Jose L Nieto-Torres | 2023/12/19 |
Positive‐strand RNA viruses—a Keystone Symposia report | Annals of the New York Academy of Sciences | Jennifer Cable Mark R Denison Margaret Kielian William T Jackson Ralf Bartenschlager | 2023/3 |
Broad spectrum antivirals against coronavirus | 2023/5/18 | ||
MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection | Virus research | Wanbo Tai Jian Zheng Xiujuan Zhang Juan Shi Gang Wang | 2023/9/1 |
Contrasting roles of MERS-CoV and SARS-CoV-2 internal proteins in pathogenesis in mice | Mbio | Lok-Yin Roy Wong Abby Odle Emma Luhmann Douglas C Wu Yiquan Wang | 2023/12/19 |
SARS-CoV-2-mediated lung edema and replication are diminished by cystic fibrosis transmembrane conductance regulator modulators | MBio | Jose M Honrubia Javier Gutierrez-Álvarez Alejandro Sanz-Bravo Ezequiel González-Miranda Diego Muñoz-Santos | 2023/2/28 |
Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responses | EMBO molecular medicine | Valeria Fumagalli Pietro Di Lucia Micol Ravà Davide Marotta Elisa Bono | 2023/5/8 |
